The limited success of disease-modifying drugs for neurological disorders highlights the urgent need for better biomarkers and a deeper understanding of the underlying biology.
Proteomics can provide unprecedented functional insights into the molecular basis of complex neurological disorders, bringing hidden pathways and new therapeutic targets to light.
Here are some examples of how we have applied proteomics to address key questions in neuroscience drug discovery and development.